Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms: PSMA, PSM, NAALAdase, NAALAD1, mGCP, GCPII, GCP2, FOLH, folate hydrolase (prostate-specific membrane antigen) 1, FGCP

| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 5 µg | $215 | 7-10 days | 7-10 days | |
| 10 µg | $359 | 7-10 days | 7-10 days | |
| 20 µg | $600 | 7-10 days | 7-10 days | |
| 50 µg | $939 | 7-10 days | 7-10 days | |
| 100 µg | $1,580 | 7-10 days | 7-10 days |
| Bioactivity | Immobilized Anti-PSMA Antibody at 2 μg/mL (100 μL/well) can bind PSMA Protein, Human, Recombinant (His & Avi), Biotinylated, the EC50 is 90-270 ng/mL. |
| Description | PSMA Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with His and Avi tag. The predicted molecular weight is 82.72 kDa and the accession number is NP_004467.1. |
| Species | Human |
| Expression System | HEK293 Cells |
| Tag | N-His-Avi |
| Accession Number | Q04609-1 |
| Construction | Lys44-Ala750 |
| Protein Purity | ≥ 95 % as determined by SDS-PAGE. ≥ 95 % as determined by SEC-HPLC. |
| Endotoxin | < 1.0 EU/μg of the protein as determined by the LAL method. |
| Formulation | Lyophilized from 0.22 μm filtered solution in 50mM MES, 150mM NaCl, 8% trehalose (pH 6.0). |
| Reconstitution | Reconstitute the lyophilized protein in 50mM MES (pH 6.0). The product concentration should not be less than 100 μg/ml. Before opening, centrifuge the tube to collect powder at the bottom. After adding the reconstitution buffer, avoid vortexing or pipetting for mixing. |
| Synonyms | PSMA, PSM, NAALAdase, NAALAD1, mGCP, GCPII, GCP2, FOLH, folate hydrolase (prostate-specific membrane antigen) 1, FGCP |
| Research Background | Glutamate carboxypeptidase 2, also known as Glutamate carboxypeptidase II, Membrane glutamate carboxypeptidase, Prostate-specific membrane antigen, GCPII, PSMA, FOLH1, and NAALAD1, is a single-pass type II membrane protein which belongs to thepeptidase M28 family and M28B subfamily. FOLH1 is highly expressed in prostate epithelium. It is detected in urinary bladder, kidney, testis, ovary, fallopian tube, breast, adrenal gland, liver, esophagus, stomach, small intestine, colon, brain (at protein level), and the capillary endothelium of a variety of tumors. FOLH1 has both folate hydrolase and N-acetylated alpha linked acidic dipeptidase (NAALADase) activity. It has a preference for tri-alpha-glutamate peptides. Genetic variation in FOLH1 may be associated with low folate levels and consequent hyperhomocysteinemia. This condition can result in increased risk of cardiovascular disease, neural tube defects, and cognitive deficits. FOLH1 also shows a promising role in directed imaging and therapy of recurrent or metastatic disease.Cancer ImmunotherapyImmune CheckpointImmunotherapyTargeted Therapy |
| Molecular Weight | 82.43 kDa (predicted); 95-115 kDa (reducing conditions due to glycosylation); 180-220 kDa (SEC-MALS) |
| Shipping | In general, lyophilized powders are shipped with blue ice, while solutions are shipped with dry ice. |
| Storage | It is recommended to store recombinant proteins at -20°C to -80°C for future use. Lyophilized powders can be stably stored for over 12 months, while liquid products can be stored for 6-12 months at -80°C. For reconstituted protein solutions, the solution can be stored at -20°C to -80°C for at least 3 months. Please avoid multiple freeze-thaw cycles and store products in aliquots. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.